The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
As hospitals restructure to gain sustainability in an era of reform, it is crucial for supply chain leaders to work collaboratively within health…
Webcast
Part 3 of the GPO or Local/Self Contracting webcast series examines whether compliance can be achieved without alignment, and vice versa.
On-Demand Educational Webinars
At Hershey Penn State Medical Center, the supply chain and ED nursing team came together in a Kaizen process to reinvent the way supplies were being…
Webcast
In this 3-part series, learn how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration.
On-Demand Educational Webinars
Cybersecurity impacts all industry verticals including health care. Health care organizations need to address security in standard technology and…
Podcasts
John Kelty from W.L.